News | Stroke | March 19, 2019

Co-founder of iSchemaView led DEFUSE 3 Study that contributed to new AHA/ASA thrombectomy guidelines

 

Gregory W. Albers, M.D., Receives Distinguished Clinical Research Achievement Award for Stroke Research

March 19, 2019 – iSchemaView announced the company’s co-founder Gregory Albers, M.D., has received the Distinguished Clinical Research Achievement Award, presented by the Clinical Research Forum. The Distinguished Clinical Research Achievement Awards are presented to the top two studies that show creativity, innovation, or a novel approach that demonstrates an immediate impact on the health and well-being of patients.

In the DEFUSE 3 study, Albers and his team used iSchemaView’s RAPID advanced medical imaging platform, exclusively, to identify stroke patients who continue to have salvageable brain tissue many hours after stroke onset. By identifying patients who are most likely to benefit from stroke therapies, the DEFUSE 3 study is credited with accelerating the development and testing of new therapeutic options, as well as enabling hospitals to offer life-saving stroke therapies to many patients who arrive after the previous standard six-hour treatment window has elapsed.

Albers is the Coyote Foundation professor of neurology and neurological sciences and professor, by courtesy, of neurosurgery at the Stanford University Medical Center. He is also director of the Stanford Stroke Center. Albers’ primary research focus is the diagnosis, management and prevention of ischemic stroke. He was instrumental in the development of RAPID, a medical imaging platform that allows physicians to identify stroke patients who have salvageable brain tissue. Due to the findings of DEFUSE 3 and other stroke studies that also employed RAPID, the American Heart Association and American Stroke Association changed their treatment guidelines for thrombectomy from six hours after onset to up to 24 hours after onset for patients with salvageable brain tissue.

Following the awards ceremony, Albers will present the results of the DEFUSE 3 study to members of Congress and discuss the critical role of federal funding for clinical research.

Read the article "Brain-Scan Guided Emergency Stroke Treatment Can Save More Lives"

For more information: www.i-rapid.com


Related Content

News | Magnetic Resonance Imaging (MRI)

February 9, 2024 — Multiple sclerosis (MS) is a neurological disease that usually leads to permanent disabilities. It ...

Time February 09, 2024
arrow
News | Artificial Intelligence

December 11, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow ...

Time December 11, 2023
arrow
News | Artificial Intelligence

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Time November 21, 2023
arrow
News | Artificial Intelligence

November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow solutions ...

Time November 09, 2023
arrow
News | Contrast Media

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Time August 17, 2023
arrow
News | Cardiac Imaging

June 9, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR) ...

Time June 09, 2023
arrow
News | Radiology Imaging

May 19, 2023 — Asymptomatic adults with a high accumulation of fat in their muscles, known as myosteatosis, are at an ...

Time May 19, 2023
arrow
News | Computed Tomography (CT)

May 17, 2023 — According to an accepted manuscript published in ARRS’ own American Journal of Roentgenology (AJR), SARS ...

Time May 17, 2023
arrow
News | Artificial Intelligence

April 12, 2023 — A global radiology artificial intelligence (AI) company, Annalise.ai, has announced it has received U.S ...

Time April 12, 2023
arrow
News | Magnetic Resonance Imaging (MRI)

February 16, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

Time February 16, 2023
arrow
Subscribe Now